Privi Speciality Chemicals Ltd (PRIVISCL) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Privi Speciality Chemicals Ltd on NSE and BSE, with an AI summary of each filing.
Announcement under Reg 30 - Transcript of Q2 Earnings Call held on October 30, 2026.
Transcript · 03 Nov 2026, 11:40 pm
Outcome of Earnings Call held on 30.10.2026 @ 04:00 pm - Audio Link
Audio / Video · 31 Oct 2026, 12:56 am
Privi Speciality Chemicals Releases Q2 and H1 FY27 Earnings Call Audio Recording Privi Speciality Chemicals Limited announced the availability of the audio recording for its Analysts/Investors Meet held on 30th Oct'26. The earnings call covered the un-audited standalone and consolidated financial results for the second quarter and half year ended 30th Sep'26. The financial results were officially approved by the company's Board of Directors at its meeting on 30th Oct'26. An accessible recording link has been submitted to both BSE and NSE for investor records.
Investor Presentation - Financial & Operational Review for Quarter and half year ended September 30,2026.
Investor Presentation · 30 Oct 2026, 3:09 pm
Privi Speciality Chemicals Delivers Strong Q2 FY27 With Robust Margin Expansion Privi Speciality Chemicals reported a strong Q2 FY27 performance, with total income rising 13.9% YoY to Rs 773.16 Cr and EBITDA increasing 16.7% YoY to Rs 212.49 Cr, expanding margins by 65 bps to 27.5%. Net profit attributable to the company grew 24.6% YoY to Rs 117.03 Cr. Balance sheet deleveraging progressed well, with net debt to EBITDA improving 32.1% YoY to 1.07x. Under its "5k:1k" roadmap, the company targets Rs 5,000 Cr in revenue and Rs 1,000+ Cr EBITDA by FY29–30.
Outcome of Board Meeting held on October 29.10.2026 to consider and approve Financial Results of Q2 FY27, declaration of Interim Dividned and Proposed investment in Solar Power Project.
Outcome · 29 Oct 2026, 7:06 pm
Outcome of Board Meeti ng - Approving Record Date for the purpose of Interim Dividend
Dividend · 29 Oct 2026, 7:01 pm
Privi Speciality Chemicals Reports Strong Q2 Results and Declares Interim Dividend Privi Speciality Chemicals declared a first interim dividend of Rs. 5 per share (record date: 4th Nov'26, payable on or before 25th Nov'26) and approved an investment limit of Rs. 2.97 cr in Opera Dwarka Projects for a Gujarat wind-solar hybrid project. For Q2 ended 30th Sep'26, consolidated revenue from operations grew 12.0% YoY to Rs. 76,045.17 lakhs. Consolidated net profit attributable to owners rose 24.6% YoY to Rs. 11,702.67 lakhs, generating a basic EPS of Rs. 29.96 compared to Rs. 24.04 in Q2 FY26.
Outcome of Board Meeting - Approval of 1st Interim Dividned FY 2026-27
Dividend · 29 Oct 2026, 6:54 pm
Privi Speciality Chemicals Reports Strong Q2 FY27 Results and Declares ₹5 Interim Dividend Privi Speciality Chemicals reported consolidated revenue from operations of ₹76,045.17 lakhs for the quarter ended 30th Sep'26, up 12.0% YoY and 14.1% QoQ. Consolidated net profit attributable to owners rose 24.6% YoY and 39.0% QoQ to ₹11,702.67 lakhs, generating a quarterly EPS of ₹29.96. The board declared a first interim dividend of ₹5 per share for FY27, setting the record date as 4th Nov'26. Additionally, the board approved an investment limit of ₹2.97 crore in Opera Dwarka Projects for a Gujarat hybrid project.
Outcome of Board Meeting - Financial Results for quarter and half year ended September 30, 2026
Financial Result · 29 Oct 2026, 6:46 pm
Privi Speciality Chemicals Limited has submitted to the Exchange, the outcome of the Board Meeting held on October 29,2026.
Outcome · 29 Oct 2026, 6:38 pm
Outcome of the Board Meeting held on October 29, 2026 inter alia to consider & approve Financial Results for quarter and half year ended September 30, 2026 & declaration of first Interim ....
Outcome · 29 Oct 2026, 6:35 pm
Privi Speciality Chemicals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 76,045 (+12.0% YoY | +14.1% QoQ) ■ EBITDA: 19,978 (+9.7% YoY | +31.2% QoQ) ■ EBITDA Margin (%): 26.3 (-55 bps YoY | +342 bps QoQ) ■ PAT: 11,703 (+24.6% YoY | +39.0% QoQ) ■ EPS (INR): 30.0 (+24.7% YoY | +39.0% QoQ)
Scrutinizer''s Report on the voting results of the business transacted at the Shareholders Meeting convened pursuant to the order dated September 07,2026 of the Honble National Company ....
Court Convened Meeting · 28 Oct 2026, 12:11 am
Privi Speciality Chemicals Shareholders Approve Scheme of Amalgamation Privi Speciality Chemicals Limited announced that its equity shareholders approved the Scheme of Amalgamation with Privi Fine Sciences Private Limited and Privi Biotechnologies Private Limited during an NCLT-convened meeting held on 27th Oct'26. The resolution passed with an 89.72% overall majority (2,66,47,091 votes in favor vs. 30,53,788 against). Among public equity shareholders, the scheme secured 60.95% approval (47,66,837 votes in favor vs. 39.05% against), satisfying the required statutory and regulatory majority thresholds under the Companies Act and SEBI regulations.
Summary of the proceedings of the NCLT Convened Meeting of the Equity Shareholders of the Company held on Tuesday, Octobers 27,2026.
Court Convened Meeting · 27 Oct 2026, 7:39 pm
Privi Speciality Shareholders Approve Merger of Two Subsidiaries Privi Speciality Chemicals Limited announced that its equity shareholders approved the Scheme of Amalgamation of Privi Fine Sciences Private Limited and Privi Biotechnologies Private Limited with the company via a special resolution with requisite majority. The decision was formalized at an NCLT-convened meeting held on 27th Oct'26 pursuant to the NCLT Mumbai Bench order dated 7th Sep'26. Final e-voting results will be declared upon receipt of the scrutinizer's report and submitted to stock exchanges.
Analyst/ Invetors Meet - Intimation to be held on Friday, October 30,2026.
Intimation · 30 Oct 2026, 4:00 pm
Privi Speciality Chemicals Schedules Q2 and H1 FY27 Earnings Call Privi Speciality Chemicals Limited will host an earnings conference call on 30th Oct'26 at 16:00 hrs IST to discuss its operational and financial performance for the quarter and half year ended 30th Sep'26 (Q2 & H1 FY27). The call will feature participation from the company's senior management team. A full transcript of the interaction will be made available on the company's official website within five working days following the conclusion of the call.
Privi Speciality Chemicals Limited has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Dividend.
Intimation · 29 Oct 2026, 5:30 am
To consider and approve the financial results for the period ended September 30, 2026 and dividend
Intimation · 29 Oct 2026, 5:30 am
Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve Intimation of Board ....
Intimation · 29 Oct 2026, 5:30 am
Privi Speciality Chemicals Schedules Board Meeting for Q2 Results and Interim Dividend Privi Speciality Chemicals Limited announced that its Board of Directors will meet on 29th Oct'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. Additionally, the board will consider recommending a first interim dividend for FY27. In compliance with insider trading regulations, the trading window for company securities has been closed since 1st Oct'26 and will reopen 48 hours after the declaration of the financial results.
Notice of Hon''ble NCLT Convened Shareholders Meeting in the matter of Scheme of Amalgamation, Scheduled to be held on Tuesday, October 27, 2026 At 12:30 p.m.
Others (Uncategorized) · 06 Oct 2026, 4:41 pm
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Mutual Funds
Acquisition/ Disposal of Shares · 25 Sept 2026, 11:19 pm
SBI Mutual Fund Trims Stake in Privi Speciality Chemicals to 7.34% SBI Mutual Fund reduced its stake in Privi Speciality Chemicals Ltd by selling 18,400 equity shares (0.0471% of paid-up capital) via open market sale on 24th Sep'26. Post-transaction, SBI Mutual Fund’s holding stands at 28,68,544 shares, or 7.3434% of the company's total voting capital, down from 7.3905% immediately prior to the sale. Overall, the fund's cumulative shareholding has decreased by over 2% from its previously disclosed holding of 9.3765% reported on 1st Jan'26, triggering regulatory disclosure under SEBI SAST Regulations.
Notice of Meetinfg of Equity Shareholders (Meeting) of the Company convened in accordance with the order of the Hon''ble National Company Law Tribunal, Mumbai Bench, to be held through ....
Court Convened Meeting · 25 Sept 2026, 12:21 am
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015.
Intimation · 17 Sept 2026, 8:03 pm
Privi Speciality Chemicals to Attend Anand Rathi Investor Conference Privi Speciality Chemicals Limited announced that company officials will attend an investor conference organized by Anand Rathi Institutional Equities in Mumbai on 22nd Sep'26, starting at 09:00 am. The interactions will include 1x1 and group meetings with analysts and institutional investors. Discussions will strictly focus on publicly available information, and no unpublished price-sensitive information (UPSI) will be shared during the event.
Intimation of Schedule of Analyst / Institutional Investor Meeting to be held on August 18,2026.
Intimation · 11 Aug 2026, 9:43 pm
Privi Speciality Chemicals to Hold Analyst and Investor Meeting Privi Speciality Chemicals Limited (PRIVISCL) announced it will attend an analyst and institutional investor meeting on 18th Aug'26. The 1x1/Group Meeting, organised by MOSL, will be held in Mumbai, starting at 09:00 am. Company officials will participate in the discussions, which will be based on publicly available information. Privi has confirmed that no unpublished price sensitive information (UPSI) is intended to be disclosed during the event. The company noted that the schedule is subject to change.
Scrutinizer''s Report on the voting results of the business transacted at the 41st Annual General Meeting (AGM)
Annual General Meeting · 10 Aug 2026, 11:39 pm
Summary of the Proceedings of 41st (Forty First) Annual General Meeting of the Company held on Friday August 07,2026.
Annual General Meeting · 07 Aug 2026, 11:31 pm
Transcript of Earning Call held on Friday July 31, 2026.
Transcript · 03 Aug 2026, 10:57 pm
Audio Recording of Analyst/ Investors Meet held on Friday July 31,2026.
Audio / Video · 31 Jul 2026, 11:20 pm
Privi Speciality Chemicals Publishes Q1 FY27 Analyst Call Recording Privi Speciality Chemicals Ltd. has released the audio recording of its analyst and investor meeting held on 31 Jul'26. The call discussed the company's un-audited standalone and consolidated financial results for the first quarter ended 30 Jun'26. The financial results were previously approved by the Board on 30 Jul'26. The recording is available on the company's website.
Investors Presentation - Financial and Operation Review for quarter ended June 30,2026.
Investor Presentation · 30 Jul 2026, 11:08 pm
Privi Speciality Chemicals Reports Strong Q1 FY27 with Double-Digit Growth Privi Speciality Chemicals reported strong Q1 FY27 results, with total income rising 20.01% YoY to Rs 681.42 Cr. EBITDA grew 18.73% to Rs 167.47 Cr, while net profit surged 35.97% to Rs 84.21 Cr. The EBITDA margin slightly compressed by 27 bps to 24.6%, partly due to a one-time fire incident costing Rs 2.78 Cr. Expansion projects are progressing as planned for commercial operations in H2 2028, supporting future growth alongside new product launches. The company maintained a healthy balance sheet with Net Debt/EBITDA at 1.33x.